Scarica l'app Stockscreener
38.85
1.17%
-0.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$39.31
Aprire:
$39
Volume 24 ore:
846.72K
Relative Volume:
1.96
Capitalizzazione di mercato:
$696.87M
Reddito:
$116.88M
Utile/perdita netta:
$-25.09M
Rapporto P/E:
-277.50
EPS:
-0.14
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
-6.39%
1M Prestazione:
+95.23%
6M Prestazione:
+78.37%
1 anno Prestazione:
+186.72%
Intervallo 1D:
$37.81
$39.31
Intervallo di 1 settimana:
$37.81
$42.90
Portata 52W:
$12.66
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Nome
Rigel Pharmaceuticals
Settore
Industria
Telefono
650-624-1100
Indirizzo
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Confronta RIGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
38.85 | 705.12M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-04-03 | Ripresa | Piper Sandler | Neutral |
| 2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2022-06-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Iniziato | B. Riley Securities | Neutral |
| 2020-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Ripresa | JP Morgan | Overweight |
| 2019-03-01 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Iniziato | Citigroup | Buy |
| 2018-05-02 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Ripresa | Piper Jaffray | Overweight |
| 2017-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Ripresa | H.C. Wainwright | Buy |
| 2017-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-31 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-30 | Reiterato | Piper Jaffray | Overweight |
| 2016-07-13 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-13 | Iniziato | Piper Jaffray | Overweight |
| 2016-04-22 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Reiterato | Stifel | Buy |
| 2012-11-29 | Iniziato | UBS | Neutral |
| 2012-11-06 | Reiterato | Oppenheimer | Outperform |
| 2012-03-26 | Iniziato | Canaccord Genuity | Hold |
| 2010-12-10 | Downgrade | MP Advisors | Outperform → Market Perform |
Mostra tutto
Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie
Price action breakdown for Rigel Pharmaceuticals Inc.July 2025 Summary & Proven Capital Preservation Methods - Newser
Tools to monitor Rigel Pharmaceuticals Inc. recovery probability2025 Key Lessons & Safe Investment Capital Preservation Plans - Newser
What high frequency data says about Rigel Pharmaceuticals Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Visualizing Rigel Pharmaceuticals Inc. stock with heatmapsJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - Newser
Historical volatility pattern of Rigel Pharmaceuticals Inc. visualizedWeekly Risk Report & Free Verified High Yield Trade Plans - Newser
Is Rigel Pharmaceuticals Inc. a candidate for recovery playJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
What Fibonacci levels say about Rigel Pharmaceuticals Inc. reboundJuly 2025 Summary & Accurate Technical Buy Alerts - Newser
Technical signs of recovery in Rigel Pharmaceuticals Inc.July 2025 Snapshot & Advanced Swing Trade Entry Plans - Newser
Rigel Pharmaceuticals Inc. stock outlook for YEARRate Cut & Risk Adjusted Buy/Sell Alerts - Newser
Applying chart zones and confluence areas to Rigel Pharmaceuticals Inc.2025 Key Highlights & High Return Stock Watch Alerts - Newser
Analyzing recovery setups for Rigel Pharmaceuticals Inc. investorsJuly 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Evaluating Rigel Pharmaceuticals Inc. with trendline analysis2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - Newser
Developing predictive dashboards with Rigel Pharmaceuticals Inc. data2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Can swing trading help recover from Rigel Pharmaceuticals Inc. losses2025 Stock Rankings & Expert Curated Trade Setups - Newser
Tick level data insight on Rigel Pharmaceuticals Inc. volatilityMarket Risk Report & Safe Entry Momentum Tips - Newser
Can technical indicators confirm Rigel Pharmaceuticals Inc.’s reversalPortfolio Profit Report & Breakout Confirmation Alerts - Newser
Will Rigel Pharmaceuticals Inc. bounce back from current support2025 Momentum Check & Daily Stock Trend Reports - Newser
Multi asset correlation models including Rigel Pharmaceuticals Inc.Market Growth Review & Low Risk Entry Point Tips - Newser
Published on: 2025-08-30 01:39:12 - Newser
Using data models to predict Rigel Pharmaceuticals Inc. stock movementJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Pattern recognition hints at Rigel Pharmaceuticals Inc. upsideGlobal Markets & Low Risk Growth Stock Ideas - Newser
What indicators show strength in Rigel Pharmaceuticals Inc.Portfolio Performance Summary & Free Long-Term Investment Growth Plans - Newser
Has Rigel Pharmaceuticals Inc. found a price floorTrade Analysis Summary & Short-Term High Return Strategies - Newser
Rigel Pharmaceuticals Azioni (RIGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):